公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development | Wang E.-Y.; Shiou-Hwei Yeh ; Tsai T.-F.; HSIANG-PO HUANG ; YUNG-MING JENG ; Lin W.-H.; Chen W.-C.; KUN-HUEI YEH ; PEI-JER CHEN ; Chen D.-S. | Proceedings of the National Academy of Sciences of the United States of America | 30 | 26 | |
1998 | Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19) - Possible clinical significance in advanced gastric cancer | KUN-HUEI YEH ; YAO-CHANG CHEN ; Shiou-Hwei Yeh ; Chen C.-P.; Lin J.-T.; ANN-LII CHENG | Anticancer Research | 46 | 43 | |
2013 | Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance | SUNG-HSIN KUO ; Chen L.-T.; CHUNG-WU LIN ; MING-SHIANG WU ; PING-NING HSU ; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; HSIU-PO WANG ; KUN-HUEI YEH ; ANN-LII CHENG | Blood Cancer Journal | 38 | 36 | |
2007 | Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression | SUNG-HSIN KUO ; Chen L.-T.; MING-SHIANG WU ; KUAN-TING KUO ; KUN-HUEI YEH ; SHIN-LIAN DOONG ; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; CHUNG-WU LIN ; Lin J.-T.; ANN-LII CHENG | Journal of Pathology | 19 | 11 | |
2006 | Disseminated Mycobacterium kansasii infection in an HIV-negative patient presenting with mimicking multiple bone metastases | Tsai C.-W.; JANN-TAY WANG ; Tsai C.-C.; KUN-HUEI YEH | Diagnostic Microbiology and Infectious Disease | 8 | 5 | |
2017 | Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer | Tsai K.-F.; JYH-MING LIOU ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; SUNG-HSIN KUO ; I-RUE LAI ; KUN-HUEI YEH ; MING-TSAN LIN ; HSIU-PO WANG ; ANN-LII CHENG ; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU | PLoS ONE | 29 | 25 | |
2017 | Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer | YI-HSIN LIANG ; Wei, C. H.; Hsu, W. H.; YU-YUN SHAO ; Lin, Y. C.; Chou, P. C.; ANN-LII CHENG ; KUN-HUEI YEH | Support Care Cancer | 10 | 10 | |
2008 | Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells | Chen K.-F.; Yeh P.-Y.; KUN-HUEI YEH ; YEN-SHEN LU ; SHANG-YI HUANG ; ANN-LII CHENG | Cancer Research | 114 | 105 | |
2004 | Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells | KUN-HUEI YEH ; ANN-LII CHENG ; Wan J.-P.; Lin C.-S.; Liu C.-C. | Anti-Cancer Drugs | 37 | 33 | |
2005 | Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors | YEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; KUN-HUEI YEH ; Kuo M.-L.; SUNG-HSIN KUO ; ANN-LII CHENG | World Journal of Gastroenterology | 26 | 25 | |
2017 | Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study | ANN-LII CHENG ; Cornelio G.; Shen L.; Price T.; Yang T.-S.; Chung I.J.; Dai G.-H.; Lin J.-K.; Sharma A.; KUN-HUEI YEH ; Ma B.; Zaatar A.; Guan Z.; Masood N.; Srimuninnimit V.; Yau T.; Gibbs P.; Wang X.; Doval D.C.; Oh S.-T.; Shim B.Y.; Gorospe C.; Wang H.-M.; Sirachainan E.; Hill A.; Suh K.W.; Beier F.; Chatterjee S.; Lim R. | Clinical Colorectal Cancer | 21 | 19 | |
2009 | EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment | Huang C.-L.; CHIH-HSIN YANG ; KUN-HUEI YEH ; Hu F.-C.; KUAN-YU CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; ANN-LII CHENG ; PAN-CHYR YANG | Lung Cancer | 43 | 36 | |
2015 | Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma | Li C.-L.; KUN-HUEI YEH ; Liu W.-H.; CHI-LING CHEN ; DING-SHINN CHEN ; PEI-JER CHEN ; Shiou-Hwei Yeh | International Journal of Cancer | 39 | 35 | |
1998 | Encephalopathy, lactic acidosis, hyperammonaemia and 5-fluorouracil toxicity (multiple letters) [1] | Valik D.; KUN-HUEI YEH ; ANN-LII CHENG | British Journal of Cancer | 3 | 5 | |
2013 | erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5) | CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; ANN-LII CHENG ; Hu F.-C.; KUN-HUEI YEH | Gastric Cancer | 0 | 0 | |
2011 | Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma | SUNG-HSIN KUO ; Weng W.-H.; Chen Z.-H.; PING-NING HSU ; MING-SHIANG WU ; CHUNG-WU LIN ; Jeng H.-J.; KUN-HUEI YEH ; Tsai H.-J.; Chen L.-T.; ANN-LII CHENG | Genes Chromosomes and Cancer | 7 | 9 | |
2012 | Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α | Wang S.-H.; Shiou-Hwei Yeh ; Lin W.-H.; KUN-HUEI YEH ; Yuan Q.; Xia N.-S.; DING-SHINN CHEN ; PEI-JER CHEN | Gastroenterology | 106 | 95 | |
2013 | Everolimus for previously treated advanced gastric cancer: Results of the randomized, double-blind, phase III GRANITE-1 study | Ohtsu A.; Ajani J.A.; Bai Y.-X.; Bang Y.-J.; Chung H.-C.; Pan H.-M.; Sahmoud T.; Shen L.; KUN-HUEI YEH ; Chin K.; Muro K.; Kim Y.H.; Ferry D.; Tebbutt N.C.; Al-Batran S.-E.; Smith H.; Costantini C.; Rizvi S.; Lebwohl D.; Van Cutsem E. | Journal of Clinical Oncology | 400 | 371 | |
2022 | Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Kang Y.-K.; Morita S.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Sameshima H.; Chen L.-T.; Boku N. | Gastric Cancer | 7 | 7 | |
2020 | Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer | Satoh T.; Kang Y.-K.; Chao Y.; Ryu M.-H.; Kato K.; Cheol Chung H.; Chen J.-S.; Muro K.; Ki Kang W.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Tanimoto M.; Chen L.-T.; Boku N. | Gastric Cancer | 43 | 39 | |